Double blind, randomized, controlled trial of convalescent plasma vs standard plasma for treating severe CORONA-19 respiratory failure: No benefit in outcomes found with convalescent plasma. https://t.co/1tLyK3Fvj2
Plasma convaleciente versus plasma estándar en pacientes con COVID- 19 aumentó los anticuerpos contra el SARS-CoV-2, pero no se asoció con un mejor resultado. https://t.co/pYPQZYpJIa
RT @SCCMPresident: Early termination of well-designed RCT comparing plasma with convalescent plasma showed a modest increase in #COVID19 an…
RT @SCCMPresident: Early termination of well-designed RCT comparing plasma with convalescent plasma showed a modest increase in #COVID19 an…
RT @SCCMPresident: Early termination of well-designed RCT comparing plasma with convalescent plasma showed a modest increase in #COVID19 an…
RT @SCCMPresident: Early termination of well-designed RCT comparing plasma with convalescent plasma showed a modest increase in #COVID19 an…
Early termination of well-designed RCT comparing plasma with convalescent plasma showed a modest increase in #COVID19 antibodies but no change in patient outcome @CritCareMed https://t.co/6dvitkQCb1
RT @CritCareMed: #FreeArticle #COVID_19 Bennett-Guerrero et al: RCT Convalescent vs Std plasma in severe #ARDS #COVID19 ❓ difference i…
RT @CritCareMed: #FreeArticle #COVID_19 Bennett-Guerrero et al: RCT Convalescent vs Std plasma in severe #ARDS #COVID19 ❓ difference i…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @RicardoInterni1: Importante revisar estudio. https://t.co/b0DfHY8fyu
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @RicardoInterni1: Importante revisar estudio.
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
Importante revisar estudio.
Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoció con un mejor resultado en mortalidad o días libre de ARM. No apoyan su uso para el tratamiento de pacientes hospitalizados. https://
#FreeArticle #COVID_19 Bennett-Guerrero et al: RCT Convalescent vs Std plasma in severe #ARDS #COVID19 ❓ difference in ab titers ❓ improved outcomes❓ Link: https://t.co/HakCTUil6L Editorial: https://t.co/NVXqb4NbUn #CritCareMed @SCCM Fig: Ab in
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
RT @IntraMednet: Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoci…
👇🏽
Estudio randomizado doble ciego en SDRA COVID-19 con PLASMA de CONVALECIENTE. Hubo aumento de anticuerpos pero NO se asoció con un mejor resultado en mortalidad o días libre de ARM. No apoyan su uso para el tratamiento de pacientes hospitalizados. https://
New2Trip: Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: Double-Blind Randomized Trial https://t.co/OXQy3Hn8fQ
RT @tripdatabase: New2Trip: Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disea…
New2Trip: Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: Double-Blind Randomized Trial https://t.co/OXQy3Hn8fQ
New2Trip: Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: Double-Blind Randomized Trial https://t.co/OXQy3Hn8fQ
New2Trip: Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: Double-Blind Randomized Trial https://t.co/OXQy3Hn8fQ
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
RT @SCCMPresident: #ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https:/…
#ConvalescentPlasma for #COVID19 increased antibody response but did not improve patient outcomes @CritCareMed https://t.co/2xcgUg8pzy
RT @DylanMSmith3: New preprint on convalescent plasma trial from SBU colleagues including our former PhD student @rome23_j : increased anti…
RT @DylanMSmith3: New preprint on convalescent plasma trial from SBU colleagues including our former PhD student @rome23_j : increased anti…
New preprint on convalescent plasma trial from SBU colleagues including our former PhD student @rome23_j : increased antibodies but no sign of improved outcomes. @SBUPublicHealth https://t.co/udo8enZEem
New article: Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial https://t.co/ia1gMIxutZ #coronavirus #COVID19 #2